Projects per year
Personal profile
Area of Expertise
The main focus of my research is to discover and develop bioactive natural products from microorganisms as drugs or drug leads for the treatment of cancer, infectious diseases, or other human medical conditions. In addition, I recently initiated a collaborative project for the engineering of novel oncolytic virus for cancer chemoimmunotherapy.
Key words: anti-aging, anti-cancer, anti-infective, crowd-sourcing, crowd-funding, drug discovery, drug development, natural product, synthetic biology, chemoimmunotherapy, contract service
Key words: anti-aging, anti-cancer, anti-infective, crowd-sourcing, crowd-funding, drug discovery, drug development, natural product, synthetic biology, chemoimmunotherapy, contract service
Education/Academic qualification
BS in Microbiology, Huazhong Agricultural University
MS in Phytochemistry, Institute of Botany of the Chinese Academy of Sciences
PhD in Botany & Microbiology, Michigan State University
Fingerprint
Dive into the research topics where Yiqiang (Eric) Cheng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 7 Finished
-
High-Resolution Tandem Mass Spectrometer for Advanced Biomolecular Research
Prokai, L., Forster, M. & Cheng, Y.
27/01/17 → 31/01/18
Project: Research
-
Discover and Engineer New Histone Deacetylase Inhibitors as Anticancer Agents
NCI: National Cancer Institute
1/06/13 → 31/05/15
Project: Research
-
Discover and Engineer New Histone Deacetylase Inhibitors as Anticancer Agents
Cheng, Y., CHENG, Y., CHENG, Y., CHENG, Y. & CHENG, Y.
1/08/10 → 30/11/15
Project: Research
-
Discover and Engineer New Histone Deacetylase Inhibitors as Anticancer Agents
CHENG, Y., Cheng, Y. & CHENG, Y.
1/08/10 → 30/11/15
Project: Research
-
Developing new targeting strategy for androgen receptor variants in castration resistant prostate cancer
Wang, B., Lo, U. G., Wu, K., Kapur, P., Liu, X., Huang, J., Chen, W., Hernandez, E., Santoyo, J., Ma, S. H., Pong, R. C., He, D., Cheng, Y. Q. & Hsieh, J. T., 15 Nov 2017, In: International Journal of Cancer. 141, 10, p. 2121-2130 10 p.Research output: Contribution to journal › Article › peer-review
-
Reconstitution of the FK228 biosynthetic pathway reveals cross talk between modular polyketide synthases and fatty acid synthase
Wesener, S. R., Potharla, V. Y. & Cheng, Y. Q., Feb 2011, In: Applied and Environmental Microbiology. 77, 4, p. 1501-1507 7 p.Research output: Contribution to journal › Article › peer-review
-
Chromobacterium spp. mediate their anti-Plasmodium activity through secretion of the histone deacetylase inhibitor romidepsin
Saraiva, R. G., Huitt-Roehl, C. R., Tripathi, A., Cheng, Y. Q., Bosch, J., Townsend, C. A. & Dimopoulos, G., 1 Dec 2018, In: Scientific Reports. 8, 1, 6176.Research output: Contribution to journal › Article › peer-review
-
Thailandepsins: Bacterial products with potent histone deacetylase inhibitory activities and broad-spectrum antiproliferative activities
Wang, C., Henkes, L. M., Doughty, L. B., He, M., Wang, D., Meyer-Almes, F. J. & Cheng, Y. Q., 28 Oct 2011, In: Journal of Natural Products. 74, 10, p. 2031-2038 8 p.Research output: Contribution to journal › Article › peer-review
-
13C labeling indicates that the epoxide-containing amino acid of HC- toxin is biosynthesized by head-to-tail condensation of acetate
Cheng, Y. Q., Le, L. D., Walton, J. D. & Bishop, K. D., 1999, In: Journal of Natural Products. 62, 1, p. 143-145 3 p.Research output: Contribution to journal › Article › peer-review